Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) EV to FCF (2021 - 2025)

Invivyd's (IVVD) quarterly EV to FCF came in at 12.86 in Q4 2025, down 2435.07% on a YoY basis from 0.55 in Q4 2024, and down 3.75% quarter-over-quarter from 12.39 in Q3 2025.

Analysis

Invivyd (IVVD) EV to FCF (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported EV to FCF for 5 consecutive years, with 12.86 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, EV to FCF fell 2435.07% year-over-year to 12.86; the trailing twelve-month figure through Dec 2025 stood at 3.41 (down 3593.21% YoY), and the FY2025 full-year result was 3.41, down 3593.21% from the prior year.
  • EV to FCF fell to 12.86 in Q4 2025 per IVVD's latest filing, from 12.39 in the prior quarter.
  • Across five years, EV to FCF topped out at 3.3 in Q4 2021 and bottomed at 35.05 in Q3 2021.
  • Historically, EV to FCF has averaged 3.99 across 5 years, with a median of 0.72 in 2022.
  • The widest YoY moves for EV to FCF: up 115.26% in 2024, down 5718.61% in 2024.
  • Over 5 years, EV to FCF stood at 3.3 in 2021, then plunged by 145.71% to 1.51 in 2022, then tumbled by 160.99% to 3.94 in 2023, then soared by 113.97% to 0.55 in 2024, then tumbled by 2435.07% to 12.86 in 2025.
  • According to Business Quant data, EV to FCF over the past three periods registered 12.86, 12.39, and 3.79 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.86
Sep 30, 2025 -12.39
Jun 30, 2025 -3.79
Mar 31, 2025 -1.18
Dec 31, 2024 0.55
Sep 30, 2024 -0.32
Jun 30, 2024 0.40
Mar 31, 2024 -6.55
Dec 31, 2023 -3.94
Sep 30, 2023 -0.14
Jun 30, 2023 0.18
Mar 31, 2023 -0.11
Dec 31, 2022 -1.51
Sep 30, 2022 -1.12
Jun 30, 2022 2.06
Mar 31, 2022 0.57
Dec 31, 2021 3.30
Sep 30, 2021 -35.05